Telomere dysfunction alters intestinal stem cell dynamics to promote cancer

被引:1
|
作者
Labella, Kyle A. [1 ]
Hsu, Wen-Hao [1 ]
Li, Jiexi [1 ]
Qi, Yutao [1 ]
Liu, Yonghong [1 ]
Liu, Jingjing [2 ]
Wu, Chia -Chin [2 ]
Liu, Yang [2 ]
Song, Zingzhi [2 ]
Lin, Yiyun [3 ]
Blecher, Jonathan M. [1 ]
Jiang, Shan [1 ]
Shang, Xiaoying [1 ]
Han, Jincheng [1 ]
Spring, Denise J. [1 ]
Zhang, Jianhua [2 ]
Xia, Yan [1 ]
Depinho, Ronald A. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA
关键词
CHROMOSOMAL INSTABILITY; TUMOR-SUPPRESSOR; OPEN-LABEL; TUMORIGENESIS; TAZEMETOSTAT; HOMEOSTASIS; MUTATIONS; EVOLUTION; HALLMARKS; CARCINOMA;
D O I
10.1016/j.devcel.2024.03.020
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Telomere dynamics are linked to aging hallmarks, and age -associated telomere loss fuels the development of epithelial cancers. In Apc-mutant mice, the onset of DNA damage associated with telomere dysfunction has been shown to accelerate adenoma initiation via unknown mechanisms. Here, we observed that Apc-mutant mice engineered to experience telomere dysfunction show accelerated adenoma formation resulting from augmented cell competition and clonal expansion. Mechanistically, telomere dysfunction induces the repression of EZH2, resulting in the derepression of Wnt antagonists, which causes the differentiation of adjacent stem cells and a relative growth advantage to Apc-deficient telomere dysfunctional cells. Correspondingly, in this mouse model, GSK3b inhibition countered the actions of Wnt antagonists on intestinal stem cells, resulting in impaired adenoma formation of telomere dysfunctional Apc-mutant cells. Thus, telomere dysfunction contributes to cancer initiation through altered stem cell dynamics, identifying an interception strategy for human APC-mutant cancers with shortened telomeres.
引用
收藏
页码:1475 / 1486.e5
页数:18
相关论文
共 50 条
  • [1] Telomere dysfunction and stem cell ageing
    Ju, Zhenyu
    Rudolph, Lenhard
    BIOCHIMIE, 2008, 90 (01) : 24 - 32
  • [2] TELOMERE DYSFUNCTION AND STEM CELL AGING
    Ju, Z.
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2013, 40 : 39 - 39
  • [3] Intestinal stem cell dynamics in homeostasis and cancer
    Ramadan, Rana
    van Driel, Milou S.
    Vermeulen, Louis
    van Neerven, Sanne M.
    TRENDS IN CANCER, 2022, 8 (05): : 416 - 425
  • [4] Telomere dysfunction causes alveolar stem cell failure
    Alder, Jonathan K.
    Barkauskas, Christina E.
    Limjunyawong, Nathachit
    Stanley, Susan E.
    Kembou, Frant
    Tuder, Rubin M.
    Hogan, Brigid L. M.
    Mitzner, Wayne
    Armanios, Mary
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2015, 112 (16) : 5099 - 5104
  • [5] Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging
    Ju, Zhenyu
    Zhang, Junling
    Gao, Yingdai
    Cheng, Tao
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (01) : 33 - 43
  • [6] Telomere dysfunction and cell cycle checkpoints in hematopoietic stem cell aging
    Zhenyu Ju
    Junling Zhang
    Yingdai Gao
    Tao Cheng
    International Journal of Hematology, 2011, 94 : 33 - 43
  • [7] Telomere dynamics, aneuploidy, stem cells, and cancer (Review)
    Pathak, S
    Multani, AS
    Furlong, CL
    Sohn, SH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2002, 20 (03) : 637 - 641
  • [8] The telomere complex and the origin of the cancer stem cell
    Torres-Montaner, A.
    BIOMARKER RESEARCH, 2021, 9 (01)
  • [9] The telomere complex and the origin of the cancer stem cell
    A. Torres-Montaner
    Biomarker Research, 9
  • [10] Telomere dynamics in a human cancer cell line
    Sprung, CN
    Sabatier, L
    Murnane, JP
    EXPERIMENTAL CELL RESEARCH, 1999, 247 (01) : 29 - 37